QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.067934v1 jpet.104.067934v2 311/1/315    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cundy, K. C. Articles by Gallop, M. A. Search for Related Content PubMed PubMed Citation Articles by Cundy, K. C. Articles by Gallop, M. A.

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

XP13512 [(±)-1-([(-Isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane Acetic Acid], A Novel Gabapentin Prodrug: I. Design, Synthesis, Enzymatic Conversion to Gabapentin, and Transport by Intestinal Solute Transporters

XenoPort, Inc., Santa Clara, California

Gabapentin is thought to be absorbed from the intestine of humans and animals by a low-capacity solute transporter localized in the upper small intestine. Saturation of this transporter at doses used clinically leads to dose-dependent pharmacokinetics and high interpatient variability, potentially resulting in suboptimal drug exposure in some patients. XP13512 [(±)-1-([(-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid] is a novel prodrug of gabapentin designed to be absorbed throughout the intestine by high-capacity nutrient transporters. XP13512 was stable at physiological pH but rapidly converted to gabapentin in intestinal and liver tissue from rats, dogs, monkeys, and humans. XP13512 was not a substrate or inhibitor of major cytochrome P450 isoforms in transfected baculosomes or liver homogenates. The separated isomers of XP13512 showed similar cleavage in human tissues. The prodrug demonstrated active apical to basolateral transport across Caco-2 cell monolayers and pH-dependent passive permeability across artificial membranes. XP13512 inhibited uptake of ¹⁴C-lactate by human embryonic kidney cells expressing monocarboxylate transporter type-1, and direct uptake of prodrug by these cells was confirmed using liquid chromatography-tandem mass spectrometry. XP13512 inhibited uptake of ³H-biotin into Chinese hamster ovary cells overexpressing human sodium-dependent multivitamin transporter (SMVT). Specific transport by SMVT was confirmed by oocyte electrophysiology studies and direct uptake studies in human embryonic kidney cells after tetracycline-induced expression of SMVT. XP13512 is therefore a substrate for several high-capacity absorption pathways present throughout the intestine. Therefore, administration of the prodrug should result in improved gabapentin bioavailability, dose proportionality, and colonic absorption compared with administration of gabapentin.

Address correspondence to: Dr. Kenneth C. Cundy, XenoPort, Inc., 3410 Central Expressway, Santa Clara, CA 95051. E-mail: kcundy{at}xenoport.com

This article has been cited by other articles:

				R. Lal, J. Sukbuntherng, E. H. L. Tai, S. Upadhyay, F. Yao, M. S. Warren, W. Luo, L. Bu, S. Nguyen, J. Zamora, et al. Arbaclofen Placarbil, a Novel R-Baclofen Prodrug: Improved Absorption, Distribution, Metabolism, and Elimination Properties Compared with R-Baclofen J. Pharmacol. Exp. Ther., September 1, 2009; 330(3): 911 - 921. [Abstract] [Full Text] [PDF]

				C. A. Kushida, P. M. Becker, A. L. Ellenbogen, D. M. Canafax, R. W. Barrett, and The XP052 Study Group Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS Neurology, February 3, 2009; 72(5): 439 - 446. [Abstract] [Full Text] [PDF]

				K. C. Cundy, S. Sastry, W. Luo, J. Zou, T. L. Moors, and D. M. Canafax Clinical Pharmacokinetics of XP13512, a Novel Transported Prodrug of Gabapentin J. Clin. Pharmacol., December 1, 2008; 48(12): 1378 - 1388. [Abstract] [Full Text] [PDF]

				K. C. Cundy, T. Annamalai, L. Bu, J. De Vera, J. Estrela, W. Luo, P. Shirsat, A. Torneros, F. Yao, J. Zou, et al. XP13512 [({+/-})-1-([({alpha}-Isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane Acetic Acid], A Novel Gabapentin Prodrug: II. Improved Oral Bioavailability, Dose Proportionality, and Colonic Absorption Compared with Gabapentin in Rats and Monkeys J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 324 - 333. [Abstract] [Full Text] [PDF]